Amalia AzzaritiSenior Scientist, Clinical Experimental Oncology Laboratory, Via Hahnemann, 10 - 70126 Bari - ItalyInterests: 15 publications, - grants, Editor of Frontiers in BioscienceSpecial Issues and Topics in IMR Press journals
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.
- ArticleInfluence of polymorphisms on EGFR targeted therapy in non-small-cell lung cancerElisa Giovannetti, Lale Erdem, Efnan Olcay, Leticia G Leon, Godefridus J. PetersFront. Biosci. (Landmark Ed) 2011, 16(1), 116–130; https://doi.org/10.2741/3679(This article belongs to the Special Issue Targeting EGFR pathway: from single to combined targeting EGFR pathway)15Downloads7Citations32Views
- ArticleEGFR tyrosine kinase inhibitors and multidrug resistance: perspectivesNicola A Colabufo, Marialessandra Contino, Mauro Niso, Francesco Berardi, ... Roberto PerroneFront. Biosci. (Landmark Ed) 2011, 16(5), 1811–1823; https://doi.org/10.2741/3823(This article belongs to the Special Issue Targeting EGFR pathway: from single to combined targeting EGFR pathway)20Downloads11Citations56Views
- Article
EGFR tyrosine kinases inhibitors in cancer treatment: in vitro and in vivo evidence
Anna Elisa Quatrale, Letizia Porcelli, Nicola Silvestris, Giuseppe Colucci, ... Amalia AzzaritiFront. Biosci. (Landmark Ed) 2011, 16(5), 1962–1972; https://doi.org/10.2741/3833(This article belongs to the Special Issue Targeting EGFR pathway: from single to combined targeting EGFR pathway)74Downloads33Citations74Views - ArticleAnti-EGFR monoclonal antibody in cancer treatment: in vitro and in vivo evidenceAnna Elisa Quatrale, Daniela Petriella, Letizia Porcelli, Stefania Tommasi, ... Amalia AzzaritiFront. Biosci. (Landmark Ed) 2011, 16(5), 1973–1985; https://doi.org/10.2741/3834(This article belongs to the Special Issue Targeting EGFR pathway: from single to combined targeting EGFR pathway)144Downloads6Citations166Views